The current LSL market cap is 30.91M. The company's latest EPS is CAD -0.1028 and P/E is -3.60.
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Total Revenue | 0 | 10.03M |
Operating Income | -3k | -6.67M |
Net Income | -74k | -8.47M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Total Assets | 25k | 30.9M |
Total Liabilities | 285k | 22.25M |
Total Equity | -260k | 8.66M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Operating | -3k | -7.07M |
Investing | N/A | -1.02M |
Financing | 3k | 8.1M |
Market Cap | 30.91M |
Price to Earnings Ratio | -3.60 |
Price to Sales Ratio | 3.04 |
Price to Cash Ratio | 3.7k |
Price to Book Ratio | 3.52 |
Dividend Yield | - |
Shares Outstanding | 82.44M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (1.32%) |
Company Name | LSL Pharma Group Inc |
Address |
540, rue d’avaugour, boucherville quebec city, quebec J4B 0G6 |
Website | https://www.groupelslpharma.com |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.